Follow The Filings

HCA HCA Healthcare

HCA Healthcare earnings company data as of 6:51 PM ET 10/23

  • 1 of 1 EPS beats
  • 7 Owners
  • Rank #176
  • Max 3.5%
  • Master 0.30%

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 6.66 — —
Rev $19.33B — —
FY2026 Q2 24 Jul EPS 7.56 7.59 Beat +0.4%
Rev $19.76B $20.23B Beat +2.4%

Who owns this now

Largest portfolio weights among holders, up to 3.5% (Lewis Sanders, Sanders Capital). Not free-float ownership.

All holders
  1. Lewis Sanders Reduce 3.5%
  2. Lyrical Asset Management Reduce 3.2%
  3. First Eagle Investment Manage... Add 2.1%
  4. Thomas Gayner Add 0.25%
  5. Richard Pzena Add 0.11%
  6. Bill Nygren / Oakmark Reduce 0.08%

Insider trades

Open-market buys and sales by HCA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HCA insider trades
  • None no insider bought on the open market
  • $31.1M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Michael R McAlevey EVP & Chief Legal & Admin Off.
    Sale
    $904K 1,694 shares at $533.37 16% of stake
    Traded Feb 18 Filed Feb 18
  2. Christopher F. Wyatt SVP & Controller
    Sale
    $2M 4,000 shares at $505.00 8.3% of stake
    Traded Feb 11 Filed Feb 12
  3. Jennifer Berres SVP & Chief Human Res. Officer
    Sale
    $4.1M 8,020 shares at $514.58 40% of stake
    Traded Feb 11 Filed Feb 12
  4. Samuel N Hazen CEO
    Sale
    $21.5M 42,877 shares at $501.04 57% of stake
    Traded Feb 3 Filed Feb 5
  5. Michael S. Cuffe EVP and Chief Clinical Officer
    Sale
    $747K 1,500 shares at $498.09 4.8% of stake
    Traded Feb 3 Filed Feb 5
  6. Michael R McAlevey EVP & Chief Legal & Admin Off.
    Sale
    $1.8M 3,892 shares at $473.79 53% of stake
    Traded Nov 5, 2025 Filed Nov 5, 2025

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants, 14 share withholdings for taxes, 14 other transactions, 7 gifts, and 6 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 2.03,8.01
10-Q
8-K 2.02,7.01,8.01,9.01
8-K 2.02,7.01,9.01
8-K 5.02
SCHEDULE 13G —
8-K 1.01,2.03,8.01,9.01
10-Q
424B5
8-K 5.07
424B3
8-K 8.01,9.01
8-K 2.02,7.01,8.01,9.01
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.